Preliminary results in the application of radiobiological models in the evaluation of radiotherapy plans

Notwithstanding the limitations of radiobiological models in the clinical application, its use is becoming more widespread in order to quantitatively assess the bioequivalence of different regimens of irradiation, the effective comparison between different treatment plans by estimating the probability tumor control (TCP) or the probability of normal tissue complication (NTCP), or solve problems, such as the rescheduling of treatments in case of failure. The response to irradiation in the tissues at risk (OARS) depends on factors such as volume irradiated or its organizational structure and behavior can vary for a given dose distribution. Another important aspect is the sensitivity of these models to the variation of parameters (α, α / β, proliferation, clonogenic density, etc.) Measuring the difference between-subjects. Commercial planning systems do not always possible to estimate the biological response of the OARS and CTV. This study presents an assessment of the results of two applications (free ware) and Albireo Target BIOPLAN Cygnus X1 that calculate statistical parameters of the DVH: equivalent uniform dose (EUD), equivalent biological dose (BED), medium dose and other to estimate TCP (Poisson model) and NTCP (Lyman-Kutcker models-Burman and relative seriality) for the calculation of the objective functions: the probability of uncomplicated control (UTCP) based on generalized EUD (f). We studied the response of both systems to the variation of relevant radiobiological parameters and the shape of the DVH. (Author)